From May 21 to 23, the 92nd China International Pharmaceutical Ingredients Exhibition (API China) was held in Guangzhou. Under the theme of "Technology Leads, Craftsmanship Creates," the event attracted nearly 4,000 exhibitors from home and abroad, over 500 industry experts, and 200,000 professional visitors.

Tianjin Pharma made thorough preparations for the exhibition. A delegation led by Xu Hua — Vice President of Tianjin Pharmaceuticals Group, and Party Secretary and Chairman of Tianjin Pharma— attended the event, showcasing the Company's core product portfolio in the API sector.

During the exhibition, numerous industry professionals and both existing and new clients visited Tianjin Pharma’s booth. Staff from the Active Pharmaceutical Ingredients (API) Sales Center and Manufacturing Center engaged in in-depth, face-to-face communication with visitors, providing detailed introductions to the company's product features, advantages, and application fields. These efforts aimed to precisely align with market demands and further expand cooperation channels. The company also held discussions with several renowned domestic and international enterprises on joint R&D and market expansion, reaching preliminary cooperation intentions.

The event comprehensively demonstrated Tianjin Pharma's integrated strengths in API R&D, production, and market services. In the future, Tianjin Pharma will continue to dedicate itself to R&D and innovation, consistently enhance product competitiveness and influence, and drive high-quality development of the enterprise.